Buy Canadian Insulin’s Post

Dr. Haggerty has published a lot of papers, but this may be one of the most important ones. With her research team, she conceptualized it, implemented it, and published it amazingly quickly. Patients around the country are experiencing unprecedented benefits from GLP1 anti-obesity medications only to have access to those medications stripped from them mid-treatment if insurance plans stop coverage. This is the first qualitative study to assess the impact on these patients. Insurances must do better. They should have strategies to get the right people on the right treatments for obesity and should not take people doing well off of treatment. https://lnkd.in/eq5RV97R

💡A new study has estimated the prevalence of paroxysmal nocturnal hemoglobinuria in adult patients with insurance in the United States from 2018 to 2022, along with describing the associated healthcare resource utilization and costs of #C5Inhibitors including #eculizumab, #pegcetacoplan, and #ravulizumab. Read the findings here: https://brnw.ch/21wLfqq #RareDiseaseResearch

As GLP-1 medications continue to demonstrate their value in managing chronic conditions like diabetes and obesity, employers face the challenge of balancing healthcare costs with outcomes. These groundbreaking treatments come with a hefty price tag, making it crucial for benefits leaders to explore strategies that align cost containment with employee well-being.

Did you know that Medicare supplements don't cover drugs? You'll need a separate drug plan for that. The cost of your Medicare supplement can vary based on your age, gender, and smoking status. Here's a crucial tip: before focusing on price or specific companies, make sure the plan meets your unique needs. Remember, what works for your neighbor might not be right for you. Your health coverage should be tailored to your situation. Always prioritize your needs to get the best fit for your Medicare plan! For more information relateed to all things insurance please reach out to Al Schiebel and his team at shopbenefits.com #MedicareTips #HealthCoverage #MedicareSupplement #DrugPlan #InsuranceAdvice

The answer to the question below is YES! Our clients would love us.❤️ Many of our clients ask if GLP-1 drugs, like Ozempic and Wegovy are covered on their group benefit plan; mainly for weight loss and pre-diabetes. Current coverage is for those diagnosed with diabetes- it is not covered as a preventive measure to those with pre-diabetes. Of course we advocate a healthy lifestyle and health monitoring- but I know many people with health conditions or hereditary factors who are pillars of health and fitness. You are your best advocate, talk to your doctor.

Despite being a significant independent risk factor for heart attacks and strokes, and regularly talked about by leading voices in longevity health like Peter Attia, why is Lipoprotein(a), Lp(a) and [pronounced "L P little a") so highly under-measured in the US? About 20% of the US population has a high volume of this largely genetic atherogenic lipoprotein, yet estimates are that only 2% of the population has had their Lp(a) measured. If you think you may be at elevated risk for an ASCVD event (you probably are, whether you admit it or not), ask your healthcare provider to check your Lp(a) at your next doctor's visit. Most insurance doesn't cover the lab test, but your out-of-pocket cost should be about $30 (at most). Learn more here: https://lnkd.in/gs-DrQpV

Next week, 4 December, I will presenting alongside Richard Botha from Curo Health, discussing modern obesity medications, Semaglutide and Tirzepatide, as well as the crucial role that diet and exercise play in metabolic health. Spoiler alert: These medications are not a silver bullet but when combined with diet and exercise can have wonderful benefits. Crucial questions around how we assess life insurance applicants who are using these medications will be one of the key take aways. #metabolichealth #lifeinsurance #riskassessment You can register to attend by clicking the link below https://lnkd.in/dV6Uxdmr

Boosting Metabolic Health = Fewer Cancer Claims? 🤔 Swiss Re, a major reinsurer, suggests that improving metabolic health could be a game-changer in reducing cancer-related insurance claims. 💪📉 The link between metabolic health (think healthy weight, blood sugar, and cholesterol levels) and cancer risk is becoming clearer. 🍎🏃♀️ By promoting healthier lifestyles, we might see a decrease in cancer cases, which is good news for both individuals and the insurance industry. 🙌 This highlights the importance of preventive healthcare and the role insurers can play in encouraging healthy habits. It's a win-win! 🎉 #insurance #health #cancer #prevention #metabolichealth Navierre https://ow.ly/cquc30sFT1t

Inflammatory bowel diseases (Crohn’s disease and Ulcerative colitis) have been increasing in incidence, affecting more and more people in recent years. As a positive scenario, industry research for novel therapies and healthcare institution investments in new treatment approaches have been improving the prognosis and perspectives for IBD care. Perhaps the clinical guidelines and especially the process to approve treatments with health insurance have followed a different pace, which raises barriers to patients receiving the best care. This article outlines the main challenges in this scenario, such as delays in cycling between treatments and/or non-coverage for additional services. Policy changes, the medical home system designed to coordinate patient care utilizing a multidisciplinary approach, and even single healthcare providers' direct actions on defined specific staff to deal with insurance processes are emerging as potential solutions. #ibd #healthcare #immunology https://lnkd.in/ef3py9DX

GLP-1 agonists are transforming the treatment of obesity, but the road ahead is complex. As demand for these medications rises 📈, insurers and employers are weighing the costs and coverage options. Learn more about GLP-1s in our article here! https://lnkd.in/g88zdrVF Subscribe to get Tools + Intel straight to your inbox here! https://lnkd.in/gmu2BKzd #healthcare #obesity #insurance